Publication | Closed Access

Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: Relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment

Metabolic SyndromeCardiovascular DiseaseMedicinePlasma LdlPhysiologyDiabetesType 2HyperlipidemiaLipoprotein MetabolismDiabetes MellitusPharmacologyAtherosclerosisDyslipidemiaHealth Sciences